DrFatemeh Geranmayeh

Dr Fatemeh Geranmayeh is a Clinical Associate Professor and an MRC funded Clinician Scientist at the Department of Brain Sciences, Imperial College London, where she leads the Clinical Language and Cognition (CLC) group. She is also an Honorary Consultant Neurologist at Imperial College Healthcare NHS Trust. She obtained a First Class Honours BSc degree in Neuroscience in 2004 for which she also recieved the Goldberg-Schachmann and Freda Becker Award from the University of London. She obtained her medical degree in 2006 and was awarded an Academic Clinical Fellowship in Neurology in 2008 funded by the NIHR. Subsequently she completed her PhD through a Wellcome Trust Research Training Fellowship in 2015. She then undertook a post-doctoral clinical fellowship at Imperial College London before completing her clinical training.

Her current research investigates the mechanisms of recovery of language and cognitive functions in patients with cerebrovascular disease and vascular dementia. She uses advanced neuroimaging, artificial intelligence and brain stimulation to study changes in behaviour and neural networks post brain injury. She is the lead for the IC3 study (ic3study.co.uk) where she investigates novel blood biomarkers of cognitive recovery after stroke.

Dr Geranmayeh runs a specialist vascular cognitive clinic. She has a clinical interest in post stroke cognitive impairment, vascular dementia and language impairment secondary to neurodegenerative diseases.

Dr Geranmayeh is co-director of VIDA (Vascular and Immune Contributions to DementiA), a multi-institutional Doctoral Training Centre funded by the Alzheimer’s Society. She is a member of The Clinical Academic Training Forum (CATF), a UK-wide group representing key stakeholders in training the future clinical academic workforce.

Dr Geranmayeh is a member of of Alzhimer's Research UK Grant Review Board and on the Clinical Advisory Group to Alzhiemer's Society.